Results 131 to 140 of about 4,596 (150)

Erlotinib in Patients with Brain Metastases for Non-small Cell Lung Cancer [PDF]

, 2009
Jiandong ZHANG, Jinming YU, Xinshuang YU
core  

[Advancements in Radiomics for Immunotherapy of Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Hou Y, Zhang T, Wang H.
europepmc   +1 more source

[Research Status and Progress of Third-generation EGFR-TKIs 
in Elderly Patients with Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Chen X, Sun Y, Zhang L, Jiang B.
europepmc   +1 more source

[Research Progress on Imaging Diagnosis of Non-small Cell Lung Cancer 
Which Invades Pleura or Chest Wall]. [PDF]

Zhongguo Fei Ai Za Zhi
Wang Y, Yuan Z.
europepmc   +1 more source

[Chinese Expert Consensus on Assessment and Clinical Application of 
Tertiary Lymphoid Structure for Non-small Cell Lung Cancer (2025 Version)]. [PDF]

Zhongguo Fei Ai Za Zhi
Lung Cancer Collaboration Group of Tumor Pathology Committee of Chinese Anti-Cancer Association, Expert Committee on Non-small Cell Lung Cancer of Chinese Society of Clinical Oncology.   +1 more
europepmc   +1 more source

[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed 
for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis]. [PDF]

Zhongguo Fei Ai Za Zhi
Chen X, He M, Chen C, Jiang C, Li H, Lin Y, Yu T, Xie Y, Guo A, Huang M, Yin Z, Zhang T.   +11 more
europepmc   +1 more source

[Savolitinib Induced Pathological Complete Response in Non-small Cell Lung Cancer with MET Amplification: A Case Report]. [PDF]

Zhongguo Fei Ai Za Zhi
Lu M, Zhang R, Li B, Xu H, Guo Y, You J, Sun B.   +6 more
europepmc   +1 more source

[Inhibitory effect of <i>Fuzheng Huaji</i> Decoction against non-small cell lung cancer cells <i>in vitro</i> and the possible molecular mechanism]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
He L, Chen X, Yan C, Shi L.
europepmc   +1 more source

[Research Progress of Antibody-conjugated Drugs in Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Liu Y, Wei S.
europepmc   +1 more source